Community-aquired pneumonia associated with coronavirus disease (COVID-19): determination of pathological process progression predictors by clinical and hemocoagulation parameters

Community-aquired pneumonia associated with coronavirus disease (COVID-19): determination of pathological process progression predictors by clinical and hemocoagulation parameters

The search for clinical and laboratory markers of COVID-19-associated CAP progression is an urgent problem of today. The aim of our study was to determine the risk factors for the burden of the pathological process by establishing the diagnostic and prognostic significance of clinical and hemocoagul...

Full description

Saved in:

Bibliographic Details
Main Authors:	T.O. Pertseva, K.O. Bielosludtseva, L.I. Konopkina, M.A. Krykhtina, O.V. Myronenko, L.A. Botvinikova, O.F. Moiseienko
Format:	Article
Language:	English
Published:	Dnipro State Medical University 2022-03-01
Series:	Medičnì Perspektivi
Subjects:	community-acquired pneumonia viral pneumonia coronavirus disease covid-19 diagnosis predictors of progression risk factors for burden d-dimer fibrinogen coagulogram
Online Access:	http://journals.uran.ua/index.php/2307-0404/article/view/254318
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Community-aquired pneumonia on the background of coronaviral disease (COVID-19): principles of diagnostics and determination of risk factors of pathological process aggravation
by: T. A. Pertseva, et al.
Published: (2020-10-01)

Clinical, general, hemocoagulation and pathologicanatomical features of patients with moderate and severe community acquired pneumonia by the data of retrospective analysis.
by: T. A. Pertseva, et al.
Published: (2017-10-01)

Neutrophil-to-lymphocyte ratio in predicting prognosis and course of community community-acquired pneumonia in hospitalized patients.
by: T. O. Pertseva, et al.
Published: (2018-04-01)

Can clinical findings at admission allow withholding of antibiotics in patients hospitalized for community acquired pneumonia when a test for a respiratory virus is positive?
by: Ryan Ward, et al.
Published: (2025-01-01)

Ventilation function of the lungs in patients after pneumonia associated with coronavirus disease (COVID-19): diagnostic significance of indicators
by: L.I. Konopkina, et al.
Published: (2022-06-01)

Features of severe community acquired pneumonia in hiv-infected patients
by: Bielosludtseva K.O.
Published: (2014-06-01)

Features of laboratory indicators of severe community-acquired pneumonia
by: Pertzeva T.A., et al.
Published: (2017-06-01)

Тhe features of severe community acquired pneumonia.
by: I. V. Avramenko
Published: (2015-06-01)

Тhe features of severe community acquired pneumonia
by: Avramenko I.V.
Published: (2015-06-01)

Features of laboratory indicators of severe community-acquired pneumonia.
by: T. A. Pertzeva, et al.
Published: (2017-06-01)

Duration of Antimicrobial Treatment in Adult Patients with Pneumonia: A Narrative Review
by: Dimitra Dimopoulou, et al.
Published: (2024-11-01)

Mycoplasma pneumoniae at the rise not only in China: rapid increase of Mycoplasma pneumoniae cases also in Spain
by: Ana Dacosta Urbieta, et al.
Published: (2024-12-01)

Immunological aspects of cytomegalovirus infection in community-acquired pneumonia among young adults.
by: K. D. Chichirelo-Konstantynovych, et al.
Published: (2018-04-01)

The forecasting of development of lung fibrosis after suffering a severe community-acquired pneumonia.
by: I. V. Avramenko
Published: (2018-05-01)

Difficult diagnosis. Clinical analysis of pneumonia overdiagnosis case
by: Pertseva T.A., et al.
Published: (2013-10-01)

Prognosis of cellular energy metabolism shifts in adolescents with community-acquired pneumonia
by: O.V. Zubarenko, et al.
Published: (2021-03-01)

Adenoviral Pneumonia Outbreak in Immunocompetent Adults—A Missed Antimicrobial Stewardship Opportunity?
by: Branimir Gjurasin, et al.
Published: (2025-01-01)

Optimizing antibiotic therapy of group IV community-acquired pneumonia patients
by: Dziublyk Ya.O.
Published: (2014-06-01)

Comparison between community-acquired pneumonia and post-obstructive pneumonia associated with endobronchial tumors
by: Wenwen Yu, et al.
Published: (2024-11-01)

Image of pulmonary and diagnosis of atypical novel coronavirus (2019-nCoV) infected pneumonia: case series of 14 patients
by: Wei-Guo WANG, et al.
Published: (2020-02-01)

Varicella pneumonia in an immunocompetent adult patient: Case report and review of the literature
by: Carlos Felipe Arias-Osorio, et al.
Published: (2024-01-01)

Peculiarities of acoustic diagnostic methods in pediatric practice (literature review, own research)
by: Yu.V. Marushko, et al.
Published: (2024-10-01)

PROBLEMS OF ANTIBIOTIC THERAPY IN KOVID-ASSOCIATED HOSPITAL PNEUMONIA
by: O.A. Savchenko, et al.
Published: (2022-06-01)

Risk factors and prediction model construction for poor outcome in asthma combined with severe community-acquired pneumonia in children
by: WANG Fanrong, et al.
Published: (2024-05-01)

Case report: The value of early application of mNGS technology in the diagnosis and treatment of severe Legionnaires’ disease: reports of two cases with different outcomes
by: Jianqing Fang, et al.
Published: (2025-02-01)

Influenza B Pneumonia with Pneumomediastinum, Subcutaneous Emphysema and Encephalitis. A Rare Presentation
by: Prachi Singh, et al.
Published: (2025-01-01)

Ventilator-Associated Pneumonia After Cardiac Arrest and Prevention Strategies: A Narrative Review
by: Harinivaas Shanmugavel Geetha, et al.
Published: (2025-01-01)

Proteomic profiling of the local and systemic immune response to pediatric respiratory viral infections
by: Emily Lydon, et al.
Published: (2025-01-01)

COMMUNITY-ACQUIRED PNEUMONIA COMPLICATED BY SEPSIS CAUSED BY KLEBSIELLA PNEUMONIAE: A CASE REPORT
by: A.V. Lavrenko
Published: (2017-12-01)

ESTIMATION OF USING MEDICATIONS OF DIFFERENT GROUPS FOR COMMUNITY-ACQUIRED PNEUMONIA TREATMENT OF PATIENTS WITH COMORBIDITIES
by: A.V. Demchuk
Published: (2017-03-01)

The effect of immunosuppression on outcomes in elderly patients with community-acquired pneumonia
by: Lixue Huang, et al.
Published: (2025-01-01)

Adult vaccination against respiratory infections in Egypt: a review of expert opinions
by: Ashraf Madkour, et al.
Published: (2024-12-01)

Evaluation of Inflammatory, Cardiac and Hematological Parameters in Hospitalized Children with COVID-19
by: Damla Geçkalan, et al.
Published: (2024-12-01)

Community versus academic hospital community-acquired pneumonia patients: a nested cohort study
by: Jennifer L.Y. Tsang, et al.
Published: (2024-11-01)

Complicated Pneumonia in a Child: Hydropneumothorax Associated with MIS-C and GAS Superinfection
by: Snezhina Lazova, et al.
Published: (2024-09-01)

Application of laboratory frailty index in predicting delirium in elderly patients with community-acquired pneumonia
by: Jingxian Liao, et al.
Published: (2024-12-01)

Chronic comorbidity of internal organs as a risk factor of complications and fatal outcome of community-acquired pneumonia.
by: Y. M. Mostovoy, et al.
Published: (2018-04-01)

Cytokine profile of bronchoalveolar secretion in prolonged course of community acquired pneumonia
by: R.V. Razumnyi
Published: (2022-03-01)

Predictors and time to poor management outcomes among pediatric patients hospitalized with pneumonia in the Gedeo Zone, southern Ethiopia: a prospective follow-up study
by: Wagaye Alemu, et al.
Published: (2025-01-01)

The assessment of physicians' and senior medical students’ knowledge in the field of community-acquired pneumonia: preliminary results of the KNOCAP-II project (2017-2019).
by: R. A. Bontsevich, et al.
Published: (2020-04-01)